Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07559136
PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

The aim of this trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS9531 injection compared with placebo in adolescents with obesity

Official title: A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of HRS9531 Injection in Chinese Adolescents With Obesity

Key Details

Gender

All

Age Range

12 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2026-05

Completion Date

2027-02

Last Updated

2026-04-30

Healthy Volunteers

No

Interventions

DRUG

HRS9531 injection;Placebo

Drug: HRS9531 injection; low dose Drug: Placebo

DRUG

HRS9531 injection;Placebo

Drug: HRS9531 injection; medium dose Drug: Placebo

DRUG

HRS9531 injection;Placebo

Drug: HRS9531 injection; high dose Drug: Placebo

Locations (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China